top of page

Publications

A small sample of key publications by our Science Team

A unique form of proliferating cell nuclear antigen is present in malignant breast cells. The DISCOVERY of ca-PCNA isoform.

Cancer Research 1998

Read More >

The Anti-Cancer Activity of a First-in-class Small-molecule Targeting PCNA 

Clinical Cancer Research 2018

Read More >

Small molecule targeting of transcription-replication conflict for selective chemotherapy

Cell Chemical Biology 2023

Read More >

Therapeutic Targeting of DNA Replication Stress in Cancer

Genes 2023

Read More >

AOH1996 targets mitochondrial dynamics and metabolism in leukemic stem cells via mitochondrial PCNA inhibition

Experimental Hematology and Oncology 2024

Read More >

Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma

Gastroenterology 2025

Read More >

RLLNEWLOGO.png

Included herein is information regarding RLL, LLC which may include, among other information, financial and/or scientific projections and prospects. Please note that the projections are based upon assumptions, some of which may change substantially before a confidential memorandum or other offering materials are prepared, some or all of which may not materialize. The information provided does not constitute any offer to sell or any solicitation of any offer to purchase any security, which offer will be made, if at all, only by a confidential memorandum or other offering materials prepared for such use and including applicable risk factors for the Company's offering and information regarding the securities laws of the applicable jurisdictions in which offers and sales are intended to occur.

© 2025 by RLL, LLC.

bottom of page